Monte Rosa Therapeutics, Inc. (GLUE)
18.80
-0.35
(-1.83%)
USD |
NASDAQ |
May 01, 16:00
18.50
-0.30
(-1.60%)
After-Hours: 20:00
Monte Rosa Therapeutics Total Assets (Quarterly) : 448.66M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 200.89B |
| Agenus, Inc. | 226.80M |
| BioRestorative Therapies, Inc. | 4.080M |
| Kyntra Bio, Inc. | 119.59M |
| Kura Oncology, Inc. | 738.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 215.60M |
| Shareholders Equity (Quarterly) | 233.06M |
| Debt to Equity Ratio | 0.1682 |
| Current Ratio | 6.123 |
| Net Debt Paydown Yield | 0.09% |